Crohn Disease Clinical Trial
Official title:
Double-blind Randomised Placebo Controlled Study Evaluating Local Co-administration of Autologous ADIpose Derived Stromal Vascular Fraction With Microfat for Refractory Perianal CROHN's Fistulas.
Autologous ADSVF constitutes an innovative therapeutic strategy that concentrates various
types of regenerative stem cells and paracrine factors able to promote angiogenesis and
tissue repair. Together with the ease of collection from a minimally manipulated
lipoaspirate, the unique properties of ADSVF offer new opportunities for fistulas' healing in
patients with CD. The use of ADSVF is currently developed in many clinical fields based on
safety and efficacy data.
Our ADICROHN pilot study evaluating safety and tolerance of local administration of
autologous ADSVF with microfat in CD patients with complex perianal fistula refractory to
conventional medical and surgical therapy showed that this novel therapeutic approach appears
feasible and safe.
However the therapeutic potential of local this combined treatment in healing refractory
perianal Crohn's fistulas still remains to be demonstrated.
The main objective of this study is to assess the efficacy of local injection of autologous
ADSVF and microfat versus placebo for the treatment of complex refractory perianal Crohn's
fistulas at week 24.
The efficacy will be assessed on clinical assessment of closure of all the external openings
that were drained at baseline, and MRI confirmation of absence of collections > 2 cm of the
treated perianal fistulas at week 24.
Autologous ADSVF constitutes an innovative therapeutic strategy that concentrates various
types of regenerative stem cells and paracrine factors able to promote angiogenesis and
tissue repair. Together with the ease of collection from a minimally manipulated
lipoaspirate, the unique properties of ADSVF offer new opportunities for fistulas' healing in
patients with CD. The use of ADSVF is currently developed in many clinical fields based on
safety and efficacy data.
Our ADICROHN pilot study evaluating safety and tolerance of local administration of
autologous ADSVF with microfat in CD patients with complex perianal fistula refractory to
conventional medical and surgical therapy showed that this novel therapeutic approach appears
feasible and safe.
However the therapeutic potential of local this combined treatment in healing refractory
perianal Crohn's fistulas still remains to be demonstrated.
B. Primary objective/endpoint The main objective of this study is to assess the efficacy of
local injection of autologous ADSVF and microfat versus placebo for the treatment of complex
refractory perianal Crohn's fistulas at week 24 (W24), The efficacy will be assessed on
clinical assessment of closure (despite gentle finger compression) of all the external
openings that were drained at baseline, and MRI confirmation of absence of collections > 2 cm
of the treated perianal fistulas at week 24.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04046913 -
The ADDapt Diet in Reducing Crohn's Disease Inflammation
|
N/A | |
| Recruiting |
NCT05169593 -
Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy
|
Phase 4 | |
| Recruiting |
NCT06116604 -
Early Bowel Resection for Terminal Ileal Crohn's Disease
|
||
| Recruiting |
NCT05316584 -
A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy
|
N/A | |
| Recruiting |
NCT05294107 -
Intestinal Organoids
|
N/A | |
| Recruiting |
NCT05627128 -
A Culturally Tailored Dietary Intervention to Treat Crohn's Disease
|
N/A | |
| Withdrawn |
NCT04349449 -
ENTYVIO in Bio-naive Patients With Moderate/Severe Crohn's Disease (CD) in Daily Practice
|
||
| Completed |
NCT05051943 -
A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
|
||
| Completed |
NCT03058679 -
Trial of Specific Carbohydrate and Mediterranean Diets to Induce Remission of Crohn's Disease
|
N/A | |
| Completed |
NCT02871635 -
BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity
|
Phase 3 | |
| Recruiting |
NCT04539665 -
Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease.
|
N/A | |
| Recruiting |
NCT04266600 -
Extended Mesenteric Excision in Ileocolic Resections for Crohn's Disease
|
N/A | |
| Recruiting |
NCT03913572 -
Treatment of Perianal Disease Using Adipose-derived Stem Cells
|
||
| Completed |
NCT03606499 -
Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases
|
||
| Completed |
NCT03668249 -
A Study to Characterize Multidimensional Model to Predict the Course of Crohn's Disease (CD)
|
||
| Terminated |
NCT04102111 -
A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease
|
Phase 2 | |
| Recruiting |
NCT04997733 -
Fecal Microbiota Transplantation in Crohn's Disease as Relay After Anti-TNF Withdrawal
|
Phase 3 | |
| Recruiting |
NCT05906576 -
Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients
|
Phase 4 | |
| Not yet recruiting |
NCT04398836 -
Preoperative Nutrition for Crohn's Disease Patients
|
Phase 3 | |
| Not yet recruiting |
NCT04502303 -
18F-FDG and 68Ga-FAPI PET/CT in Crohn's Disease
|
Phase 2 |